Odyssey Therapeutics, Inc. (ODTX) has 7 open-market insider trades by 7 insiders since 2026. Over the last six months insiders net bought $75.3M. The most active filer is TPG GP A, LLC.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| TPG GP A, LLC | — | — | 1 | $25.0M | 2026-05-11 |
| Nan (ln) Li | Dir | — | 1 | $20.0M | 2026-05-11 |
| Dimension Capital II, L.P. | Dir | — | 1 | $20.0M | 2026-05-08 |
| SR ONE Capital Management, LLC | 10% Owner | — | 1 | $10.0M | 2026-05-11 |
| Shelley Chu | Dir | — | 1 | $200K | 2026-05-11 |
| Jeffrey M. Leiden | Dir | — | 1 | $100K | 2026-05-11 |
| Jason Haas | CFO | — | 1 | $20K | 2026-05-08 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Shelley Chu | Director | Buy | $200K | 2026-05-11 |
| Nan (ln) Li | Director | Buy | $20.0M | 2026-05-11 |
| SR ONE Capital Management, LLC | 10% Owner | Buy | $10.0M | 2026-05-11 |
| TPG GP A, LLC | — | Buy | $25.0M | 2026-05-11 |
| SR ONE Capital Management, LLC | 10% Owner | Sell | $32K | 2026-05-11 |
| Dimension Capital II, L.P. | Director | Buy | $20.0M |
Companies that share insiders with ODTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-05-08 |
| Jason Haas | CFO | Buy | $20K | 2026-05-08 |
| Jeffrey M. Leiden | Director | Buy | $100K | 2026-05-08 |